Abstract:Abstract Ductal carcinoma is the most commonly diagnosed breast cancer in women, the presence of metastases drops patient five-year survival from 95% to an abysmal 27%. This makes studying the mechanisms that promote metastasis of critical importance. Research shows that the extracellular matrix (ECM) of the tumor microenvironment (TME) plays an important role in invasive ductal carcinoma (IDC) progression and metastasis. Specifically; the density, stiffness, and orientation of collagen I fibers in the stroma all impact IDC motility, invasion, and metastasis. Lysyl oxidase-like 2 (LOXL2) is a secreted enzymatic protein that is implicit in ECM remodeling. By catalyzing an oxidative reaction in peptidyl lysine/hydroxylysine present on collagen I fibers, LOXL2 initiates crosslinking of the fibers. Our previous publication demonstrates that interleukin-6-related pro-inflammatory cytokine signaling, specifically oncostatin M (OSM), led to the overexpression and secretion of the LOXL2 enzyme. This increased the metastatic potential of IDC cells by promoting the crosslinking and alignment of collagen I fibers, which in turn led to increased invasion in 3D collagen I matrices. Thus, we hypothesize that OSM-induced LOXL2 expression, secretion, and subsequent collagen I fiber crosslinking and alignment, leads to an increase in IDC metastasis. In vivo studies utilizing nude athymic mice injected with either MCF7-Luc-EV control or MCF7-Luc-OSM overexpressing cells were performed in conjunction with LOXL2 inhibition using specially designed chow containing either LOXL2 SMI or control. Further analysis of OSM signaling pathways was performed in MCF7 and MDA-MB-468 IDC cells to determine mechanism for OSM induction of LOXL2. Our studies demonstrate that canonical OSM signaling pathways (pERK, pSTAT3, and pAKT) all contribute to LOXL2 expression in MCF7 cells suggesting a possible mediator protein we identified as c-Myc. Furthermore, OSM-induced LOXL2 played a significant role in OSM promoted tumor growth and metastasis as LOXL2 inhibition led to decreased tumor size and far less metastatic lesions. We also analyzed and confirmed a synergistic interaction between OSM and interleukin-1beta (IL-1β) in LOXL2 expression. These results confirm the significance of LOXL2 expression in OSM promoted metastasis and suggests LOXL2 would be an important target for future breast cancer therapies, specifically in patients with elevated levels of OSM. Furthermore, the synergistic interaction between OSM and IL-1β in LOXL2 expression suggests that patients with high levels of both cytokines are at even greater risk of metastasis, making these great markers for determining at risk IDC patients. Citation Format: Simion Dinca, Cody Wolf, Laura Bond, Cheryl Jorcyk. OSM-induced LOXL2 expression hinges on upregulation of c-Myc and promotes tumor growth and metastasis, IL-1beta plays synergistic role in LOXL2 expression. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 3645.

LOXL3 Silencing Affected Cell Adhesion and Invasion in U87MG Glioma Cells

Lysyl Oxidase-Like 1 Predicts the Prognosis of Patients with Primary Glioblastoma and Promotes Tumor Invasion Via EMT Pathway

LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2

LOXL4 Knockdown Enhances Tumor Growth and Lung Metastasis Through Collagen-Dependent Extracellular Matrix Changes in Triple-Negative Breast Cancer.

LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT

Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration.

Abstract 3645: OSM-induced LOXL2 expression hinges on upregulation of c-Myc and promotes tumor growth and metastasis, IL-1beta plays synergistic role in LOXL2 expression

Expression of Lysyl Oxidase in Human Osteosarcoma and Its Clinical Significance: a Tumor Suppressive Role of LOX in Human Osteosarcoma Cells.

Long Noncoding RNA LINC00346 Promotes Glioma Cell Migration, Invasion and Proliferation by Up-Regulating ROCK1.

Silencing of Lncrna LBX2-AS1 Suppresses Glioma Cell Proliferation and Metastasis Through the Akt/GSK3β Pathway in Vitro.

Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2

LOXL3 Silencing Hampers the Metastasis and Angiogenesis of Gastric Cancer Cells Dependent on Ferroptosis Activation

Angi-13. Long Non-Coding Rnalinc03045 Regulates Glioblastoma Invasion Viawasf3

Dysregulation of LINC00324 promotes poor prognosis in patients with glioma

LOXL3-promoted hepatocellular carcinoma progression via promotion of Snail1/USP4-mediated epithelial-mesenchymal transition

STAT3-Induced LncRNA LINC01094 Regulates Proliferation, Apoptosis and Radiosensitivity of Glioblastoma Cells by Targeting the MiR-545-3p/UBE2N Axis

Clinical Significance of LOXL4 Expression and Features of LOXL4-associated Protein–protein Interaction Network in Esophageal Squamous Cell Carcinoma

LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer

Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment

LGALS3 Promotes Treatment Resistance in Glioblastoma and is Associated with Tumor Risk and Prognosis.

LOXL1‐AS1 Communicating with TIAR Modulates Vasculogenic Mimicry in Glioma Via Regulation of the Mir‐374b‐5p/mmp14 Axis